838469001: Trastuzumab deruxtecan (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Epidermal growth factor receptor inhibitor\Human epidermal growth factor receptor 2 inhibitor\Trastuzumab deruxtecan
\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Enzyme inhibitor protein\Trastuzumab deruxtecan
\Substance categorized by disposition\Immunomodulator\Immunosuppressant (substance)\Trastuzumab deruxtecan

\Drug or medicament (substance)\Immunosuppressant (substance)\Trastuzumab deruxtecan
\Drug or medicament (substance)\Antineoplastic agent (substance)\Epidermal growth factor receptor inhibitor\Human epidermal growth factor receptor 2 inhibitor\Trastuzumab deruxtecan
\Drug or medicament (substance)\Enzyme inhibitor protein\Trastuzumab deruxtecan
\Drug or medicament (substance)\Monoclonal antibody\Trastuzumab deruxtecan

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\...

\Enzyme inhibitor protein\Trastuzumab deruxtecan

\Antibody\Monoclonal antibody\Trastuzumab deruxtecan

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\...

\Enzyme inhibitor protein\Trastuzumab deruxtecan

\Antibody\Monoclonal antibody\Trastuzumab deruxtecan

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Trastuzumab deruxtecan
\Biological substance\Polypeptide (substance)\Protein\Enzyme inhibitor protein\Trastuzumab deruxtecan
\Biological substance\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Trastuzumab deruxtecan

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3897070019 Trastuzumab deruxtecan en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3897071015 Trastuzumab deruxtecan (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Trastuzumab deruxtecan	Is a	Human epidermal growth factor receptor 2 inhibitor	true	Inferred relationship	Some
Trastuzumab deruxtecan	Has disposition (attribute)	Immunomodulator (disposition)	true	Inferred relationship	Some
Trastuzumab deruxtecan	Is a	Enzyme inhibitor protein	true	Inferred relationship	Some
Trastuzumab deruxtecan	Has disposition (attribute)	Human epidermal growth factor receptor 2 inhibitor	true	Inferred relationship	Some
Trastuzumab deruxtecan	Is a	anticorps monoclonal chimérique souris-humain d'isotype IgG	false	Inferred relationship	Some
Trastuzumab deruxtecan	Is modification of (attribute)	Trastuzumab (substance)	false	Inferred relationship	Some
Trastuzumab deruxtecan	Is a	Antineoplastic agent (substance)	false	Inferred relationship	Some
Trastuzumab deruxtecan	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some
Trastuzumab deruxtecan	Is a	Monoclonal antibody	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing trastuzumab deruxtecan (medicinal product)	Has active ingredient	True	Trastuzumab deruxtecan	Inferred relationship	Some	1
Product containing only trastuzumab deruxtecan (medicinal product)	Has active ingredient	True	Trastuzumab deruxtecan	Inferred relationship	Some	1
Product containing trastuzumab deruxtecan in parenteral dose form (medicinal product form)	Has active ingredient	True	Trastuzumab deruxtecan	Inferred relationship	Some	1
Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form)	Has active ingredient	True	Trastuzumab deruxtecan	Inferred relationship	Some	1
Trastuzumab deruxtecan 100 mg powder for solution for infusion vial	Has precise active ingredient	True	Trastuzumab deruxtecan	Inferred relationship	Some	1
Trastuzumab deruxtecan 100 mg powder for solution for infusion vial	Has basis of strength substance (attribute)	True	Trastuzumab deruxtecan	Inferred relationship	Some	1

Reference Sets